Aigen Investment Management, LP Tandem Diabetes Care Inc Transaction History

Aigen Investment Management, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$30.43 - $53.43 $190,339 - $334,204	6,255 New	6,255 $252,000
Q2 2023 Aug 14, 2023	SELL	$24.18 - $42.46 $381,366 - $669,679	-15,772 Reduced 64.63%	8,632 $211,000
Q1 2023 May 15, 2023	BUY	$35.86 - $46.5 $520,364 - $674,761	14,511 Added 146.68%	24,404 $991,000
Q4 2022 Feb 10, 2023	BUY	$35.49 - $56.15 $351,102 - $555,491	9,893 New	9,893 $444,000
Q2 2022 Aug 02, 2022	BUY	$53.22 - $123.09 $564,557 - $1.31 Million	10,608 New	10,608 $628,000
Q1 2022 May 05, 2022	SELL	$101.89 - $150.09 $413,673 - $609,365	-4,060 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$118.18 - $153.21 $479,810 - $622,032	4,060 New	4,060 $618,000
Q1 2021 May 11, 2021	SELL	$81.28 - $104.34 $466,059 - $598,285	-5,734 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$86.4 - $121.75 $495,417 - $698,114	5,734 New	5,734 $549,000

360

72.5M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.98B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.